Back to search results
NCT06384183

Kerecis Real-World Fish Skin Graft Registry

Enrolling by Invitation
Not specifiedAll AgesObservational
Kerecis Ltd.
~600 participants
Updated 2024-12-30 on ClinicalTrials.gov
What's tested:Kerecis Fish Skin Graft

At a glance

Recruiting sites
0 of 6 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Fish Skin Graft Device Related failure
Measured over 12 months
+2 more outcomes measured

Conditions

Wounds
Pressure Ulcer
Diabetic Foot Ulcer
Venous Leg Ulcer
Surgical Wound
Soft Tissue Reinforcement

Explore related trials

Diabetic foot ulcerPressure SoreSoft Tissue ReinforcementStasis ulcerSurgical woundWound

Where it's being run

6 sites across 4 states
Florida2
Ohio2
North Carolina1
Texas1

Study leadership

  • Anne Swearingen · PRINCIPAL_INVESTIGATOR · Kerecis Ltd.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Provided informed consent
Has at least one target wound treated with a Kerecis device according to physician medical judgement within one calendar month prior to the registry enrollment date

Exclusion

None

What this trial measures

  • Fish Skin Graft Device Related failure12 months

    Proportion of patients with Kerecis FSG device-related failure for any reason (e.g., resulting in non-absorption or device removal)

  • Fish Skin Graft Device related allergy12 months

    Proportion of patients with Kerecis FSG device-related allergy, hypersensitivity and/or autoimmune reaction (with or without documented auto-antibody development)

  • Target Wound Infection12 months

    Proportion of patients who develop target wound infection